{"id":108399,"date":"2021-05-25T10:39:02","date_gmt":"2021-05-25T10:39:02","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=108399"},"modified":"2021-05-25T10:39:02","modified_gmt":"2021-05-25T10:39:02","slug":"borjeson-forssman-lehmann-syndrome","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/","title":{"rendered":"Borjeson-forssman-lehmann syndrome"},"content":{"rendered":"<p>Borjeson-Forssman-Lehmann syndrome (BFLS) is an X- linked, possibly incompletely recessive, genetic disorder characterized by numerous dysmorphic anomalies, obesity, hypogonadism, epilepsy, and mental retardation. The full expression in males results in more severe symptoms, whereas penetrance in carrier females appears to be associated with variable X-chromosome inactivation. In heterozygous women, the phenotypic effects vary widely between apparent normality to mild or moderately evident BFLS manifestations.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Borjeson-Forssman-Lehmann syndrome (BFLS) is an X- linked, possibly incompletely recessive, genetic disorder characterized by numerous dysmorphic anomalies, obesity, hypogonadism, epilepsy, and mental retardation. The full expression in males results in more severe symptoms, whereas penetrance in carrier females appears to be associated with variable X-chromosome inactivation. In heterozygous women, the phenotypic effects vary widely between [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-108399","post","type-post","status-publish","format-standard","hentry","category-b"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Borjeson-forssman-lehmann syndrome - Definition of Borjeson-forssman-lehmann syndrome<\/title>\n<meta name=\"description\" content=\"Borjeson-Forssman-Lehmann syndrome (BFLS) is an X- linked, possibly incompletely recessive, genetic disorder characterized by numerous dysmorphic anomalies, obesity, hypogonadism, epilepsy, and mental retardation. The full expression in males results in more severe symptoms, whereas penetrance in carrier females appears to be associated with variable X-chromosome inactivation. In heterozygous women, the phenotypic effects vary widely between apparent normality to mild or moderately evident BFLS manifestations.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Borjeson-forssman-lehmann syndrome - Definition of Borjeson-forssman-lehmann syndrome\" \/>\n<meta property=\"og:description\" content=\"Borjeson-Forssman-Lehmann syndrome (BFLS) is an X- linked, possibly incompletely recessive, genetic disorder characterized by numerous dysmorphic anomalies, obesity, hypogonadism, epilepsy, and mental retardation. The full expression in males results in more severe symptoms, whereas penetrance in carrier females appears to be associated with variable X-chromosome inactivation. In heterozygous women, the phenotypic effects vary widely between apparent normality to mild or moderately evident BFLS manifestations.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-25T10:39:02+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/\",\"name\":\"Borjeson-forssman-lehmann syndrome - Definition of Borjeson-forssman-lehmann syndrome\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-25T10:39:02+00:00\",\"dateModified\":\"2021-05-25T10:39:02+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Borjeson-Forssman-Lehmann syndrome (BFLS) is an X- linked, possibly incompletely recessive, genetic disorder characterized by numerous dysmorphic anomalies, obesity, hypogonadism, epilepsy, and mental retardation. The full expression in males results in more severe symptoms, whereas penetrance in carrier females appears to be associated with variable X-chromosome inactivation. In heterozygous women, the phenotypic effects vary widely between apparent normality to mild or moderately evident BFLS manifestations.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Borjeson-forssman-lehmann syndrome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Borjeson-forssman-lehmann syndrome - Definition of Borjeson-forssman-lehmann syndrome","description":"Borjeson-Forssman-Lehmann syndrome (BFLS) is an X- linked, possibly incompletely recessive, genetic disorder characterized by numerous dysmorphic anomalies, obesity, hypogonadism, epilepsy, and mental retardation. The full expression in males results in more severe symptoms, whereas penetrance in carrier females appears to be associated with variable X-chromosome inactivation. In heterozygous women, the phenotypic effects vary widely between apparent normality to mild or moderately evident BFLS manifestations.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/","og_locale":"en_US","og_type":"article","og_title":"Borjeson-forssman-lehmann syndrome - Definition of Borjeson-forssman-lehmann syndrome","og_description":"Borjeson-Forssman-Lehmann syndrome (BFLS) is an X- linked, possibly incompletely recessive, genetic disorder characterized by numerous dysmorphic anomalies, obesity, hypogonadism, epilepsy, and mental retardation. The full expression in males results in more severe symptoms, whereas penetrance in carrier females appears to be associated with variable X-chromosome inactivation. In heterozygous women, the phenotypic effects vary widely between apparent normality to mild or moderately evident BFLS manifestations.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/","og_site_name":"Glossary","article_published_time":"2021-05-25T10:39:02+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/","name":"Borjeson-forssman-lehmann syndrome - Definition of Borjeson-forssman-lehmann syndrome","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-25T10:39:02+00:00","dateModified":"2021-05-25T10:39:02+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Borjeson-Forssman-Lehmann syndrome (BFLS) is an X- linked, possibly incompletely recessive, genetic disorder characterized by numerous dysmorphic anomalies, obesity, hypogonadism, epilepsy, and mental retardation. The full expression in males results in more severe symptoms, whereas penetrance in carrier females appears to be associated with variable X-chromosome inactivation. In heterozygous women, the phenotypic effects vary widely between apparent normality to mild or moderately evident BFLS manifestations.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/borjeson-forssman-lehmann-syndrome\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Borjeson-forssman-lehmann syndrome"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=108399"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108399\/revisions"}],"predecessor-version":[{"id":108400,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108399\/revisions\/108400"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=108399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=108399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=108399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}